1. Bierling, R.: Experimental investigations on problems of the clinical use of 1-asparaginase. Recent Progr. Cancer Res. 33, 114 (1970).
2. Bond, V. P., Fliedner, T. M., Cronkite, E. P., Rubini, J. R., Robertson, J. S.: Cell turnover in blood and blood-forming tissues studied with tritiated thymidine. In P. Stohlman (Ed.): The kinetics of cellular proliferation, p. 188if. New York and London: Grime & Stratton 1959.
3. Broome, J. D.: Evidence that the 1-asparaginase activity of guinea pig serum is responsible for its antilymphoma effects. Nature (Lond.) 191, 1114 (1961).
4. De Barros, T., Cunha Filio, M., Ferreira De Santa, C., Valenca, M., Pereira Da Silva, M., Gijedes, J., De Carvalho, A. R. L.: Utilizacao da 1-asparaginase em paciente humano portador de neoplasia maligna. An. Fac. Med. Recife 25, 21 (1965).
5. Dolowy, W. C., Henson, D., Cornet, J., Sellin, H.: Toxic and antineoplastic effects of 1-asparaginase. Study of mice with lymphome and normal monkeys and report on a child with leukemia. Cancer (Philad.) 19, 1813 (1966).